Document Detail


No identifiable effect of ginseng (Gericomplex) as an adjuvant in the treatment of geriatric patients.
MedLine Citation:
PMID:  9061129     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study aimed to examine the effect of ginseng as an adjuvant to treatment and rehabilitation of geriatric patients in a double blind, controlled clinical trial. The treatment group (N = 24) received two capsules of Gericomplex (ginseng, vitamins, minerals and trace elements) daily for 8 weeks, while the control group (N = 25) had identical-looking placebo capsules. Participants consisted of 60 geriatric patients, mean age 77.9 years. The principal study variables were length of stay in hospital, and activities of daily living according to the Barthel ADL Index. Cognitive function was assessed at baseline and after 8 weeks, using the Mini-Mental State Examination, the Kendrick Object Learning test, and the Trail Making test. Somatic symptoms, and symptoms of depression and anxiety were scored on a 23-question version of the Hopkins Symptom Checklist. Length of stay in hospital did not differ in the two groups, which also improved to the same degree on the various functional outcome measures, except for the Kendrick Object Learning test, where the placebo group improved more markedly. In conclusion, no identifiable effect of ginseng as an adjuvant to treatment and rehabilitation of geriatric patients was observed.
Authors:
B Thommessen; K Laake
Related Documents :
15905659 - Association of hemoglobin levels, acute hemoglobin decrease, age, and co-morbidities wi...
17852309 - Cognitive-behavioural stimulation protocol for severely brain-damaged patients in the p...
443109 - Prediction of outcome of patients admitted to a geriatric department.
15058119 - Post anaesthesia care unit discharge: a clinical scoring system versus traditional time...
3760919 - A comparative assessment of home versus hospital comprehensive treatment for advanced c...
10206609 - The berg balance scale as a predictor of length of stay and discharge destination in an...
11835109 - When and how to assess quality of life in chronic lung disease.
16801459 - Bosentan therapy in patients with eisenmenger syndrome: a multicenter, double-blind, ra...
17640389 - Mental health measures of anxiety and depression in patients with retinal detachment.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Aging (Milan, Italy)     Volume:  8     ISSN:  0394-9532     ISO Abbreviation:  Aging (Milano)     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-05-23     Completed Date:  1997-05-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9102503     Medline TA:  Aging (Milano)     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  417-20     Citation Subset:  IM    
Affiliation:
Department of Geriatric Medicine, Ullevaal Hospital, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Pharmaceutic / therapeutic use*
Aged
Aged, 80 and over
Cardiovascular Diseases / rehabilitation,  therapy*
Double-Blind Method
Female
Geriatrics / methods*
Humans
Lung Diseases / rehabilitation,  therapy*
Male
Mental Disorders / rehabilitation,  therapy*
Musculoskeletal Diseases / rehabilitation,  therapy*
Panax*
Plants, Medicinal*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adjuvants, Pharmaceutic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tilt test results in young and elderly patients with syncope of unknown origin.
Next Document:  Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects.